How do I transition from active treatment to surveillance for Breast Cancer

Transitioning from Active Treatment to Surveillance for Breast Cancer

This is an important question that marks a significant milestone in your cancer journey. Let me explain how this transition typically works and what you should expect.

Understanding the Transition

Active treatment (chemotherapy, radiation, surgery, hormone therapy, etc.) focuses on destroying cancer cells and controlling the disease. Surveillance (also called follow-up care) shifts the focus to monitoring for any signs of recurrence while managing side effects and supporting your overall health.

According to the NCCN Guidelines for Patients: Metastatic Breast Cancer, this transition is carefully planned based on how your cancer responds to treatment. Your care team will determine the right timing based on:

• How well your cancer responded to treatment
• Your overall health and performance status
• Any remaining side effects
• Your specific breast cancer type (hormone receptor status, HER2 status, and other biomarkers)

What Surveillance Typically Includes

The NCCN Guidelines emphasize that it is important to keep any follow-up doctor visits and imaging test appointments. Your surveillance plan will likely include:

Regular Doctor Visits

• Scheduled appointments with your oncologist (frequency depends on your situation)
• Physical exams to check for any new symptoms or changes

Imaging Tests

• Periodic scans or imaging studies to monitor for recurrence
• The type and frequency depend on your cancer stage and characteristics

Blood Tests

• Regular lab work to monitor your overall health
• Tests to check for any signs of cancer recurrence

Symptom Monitoring

• You should report any new symptoms to your care team, such as:
  • Headaches
  • Shortness of breath with walking
  • Bone pain
  • Any other unusual changes you notice

Important Points About Surveillance

According to NCCN Guidelines, a person is a cancer survivor from the time of diagnosis until the end of life. This means:

• Surveillance is ongoing, not a one-time event
• Your care team will continue monitoring you long-term
• Side effects from treatment can be managed during this phase
• If you're on endocrine therapy (hormone therapy), you'll continue taking it exactly as prescribed—don't miss or skip doses

Questions to Ask Your Oncology Team

To help plan YOUR specific surveillance approach, ask your doctor:

1. When will my active treatment end, and when does surveillance begin?
2. How often will I need follow-up appointments, and for how long?
3. What imaging tests will I need, and how frequently?
4. If I'm on endocrine therapy, how long should I continue it?
5. What symptoms should I report immediately versus at my next appointment?
6. Will my surveillance plan change based on how I'm doing?
7. How will you monitor for side effects from my treatment?

Continuing Your Care

The NCCN Guidelines recommend:

• Keep your primary care physician (PCP) informed of changes to your care team and any new symptoms
• Continue routine medical care for your overall health
• Maintain communication with your care team about any concerns
• Stay organized with copies of your test results and treatment records

Working with Your Care Team

Your oncologist will create a personalized surveillance plan based on your specific cancer characteristics (like whether it's hormone receptor-positive, HER2-positive, or has other biomarkers that were tested). This plan may evolve over time as your situation changes.

---

This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions about your specific transition from active treatment to surveillance.